Skip to main content
Open Access Publications from the University of California

Dermatology Online Journal

Dermatology Online Journal bannerUC Davis

Morphea secondary to interferon beta1b injection: a case and review of the literature

  • Author(s): Ozlu, Emin;
  • Karadag, Ayse Serap;
  • Akdeniz, Necmettin;
  • Uzuncakmak, Tugba Kevser;
  • Zemheri, Ebru;
  • Ozkanli, Seyma
  • et al.

Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNβ1b injection is very rare

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View